GCC supply disruptions and rising global prices boost outlook for Indian aluminium producers, with integrated players likely to benefit from tighter supply
Sebi moves to tighten conflict norms, but limited disclosures and voluntary code risk falling short of restoring investor trust in the regulator's independence
The Code is an ambitious attempt to consolidate three securities laws into a single, modern statute
XED says it will tap the market at an appropriate time in the future
Nifty outlook hinges on oil and geopolitics, with Bernstein projecting a wide 19,900-27,500 range depending on conflict trajectory and crude price trends
Indices advance 3.5% in two sessions; gold prices rise again
Regulator seeks to standardise metrics and strengthen oversight of critical IT systems across market infrastructure institutions, including exchanges and depositories
Among others Dr. Reddy's, Apollo Hospitals, M&M Finance, Muthoot Finance, Tata Power, Balrampur Chini and Sammaan Capital soared up to 20% from recent lows to cross the long-term average, shows data.
Indian equities rallied after the US delayed strikes on Iran, but gains were capped by elevated oil prices and continued uncertainty around the conflict
Power Grid's strong capex pipeline and improved execution support growth outlook, but elevated valuations temper upside for the regulated utility
Temasek-backed Manipal Hospitals has filed its DRHP for a $1 billion-plus IPO, which could become the largest public issue in India's healthcare sector
Nearly 3 million accounts added at peak, just before prices reversed
New investments in pooled vehicles will be permitted, provided they are professionally managed by regulated market intermediaries
XED Institute may extend its IPO subscription window by three days amid weak demand and global uncertainty, with bids reaching only about 5 per cent so far.
The IPO comprises a fresh issue of 1 crore equity shares and an offer for sale of 25 lakh equity shares
The case stems from Sebi's examination of quarterly filings of Accuracap Vectra Fund, a scheme under Accuracap Prime Opportunities Fund, for FY24
Sensex and Nifty extend gains for a third session on easing crude volatility and bargain buying, though geopolitical tensions and inflation risks continue to cap upside
Do not exit in panic or buy falling stocks without reassessing fundamentals; instead, build a watchlist and invest gradually with a disciplined, long-term approach
Powerica and Sai Parenteral IPOs will open on March 24 amid mixed investor sentiment, while GSP Crop Science's ₹400-crore issue saw 1.61 times subscription